Filippo Lococo

37PUBLICATIONS
106CO-AUTHORS
Predictive and prognostic markersCancer diagnosisNeonatologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (37)

|Jun 17, 2025
BRCA1-Associated Protein 1 and Enhancer of Zeste Homolog 2: Pathway Interaction and Therapeutic Intervention in Breast Cancer, Mesothelioma, and Lymphoma.

Elizabeth Casey West, Jessica Evangelista, Annalisa Campanella

|Apr 25, 2025
Low-Malignant-Potential Adenocarcinoma: A Histological Category with a Significantly Better Prognosis than Other Solid Adenocarcinomas at IA Stage.

Marco Chiappetta, Alessandra Cancellieri, Filippo Lococo

|Apr 12, 2025
The Role of ctDNA for Diagnosis and Histological Prediction in Early Stage Non-Small-Cell Lung Cancer: A Narrative Review.

Carolina Sassorossi, Jessica Evangelista, Alessio Stefani

|Nov 18, 2024
Artificial intelligence applications in personalizing lung cancer management: state of the art and future perspectives.

Filippo Lococo, Galal Ghaly, Sara Flamini

|Oct 25, 2024
Unraveling Pneumomediastinum in COVID-19 Patients: Insights from a High-Volume-Center Case-Control Study.

Khrystyna Kuzmych, Marcello Covino, Mattia Paratore

|Oct 07, 2024
Impact of Comprehensive Genome Profiling on the Management of Advanced Non-Small Cell Lung Cancer: Preliminary Results From the Lung Cancer Cohort of the FPG500 Program.

Antonio Vitale, Luca Mastrantoni, Jacopo Russo

Pageof 7

Frequent Collaborators

20 joint publications

Marco Chiappetta

10 joint publications

Dania Nachira

8 joint publications

Maria Teresa Congedo

6 joint publications

Luca Boldrini